Adicet Bio Inc (ACET)
1.875
-0.22
(-10.71%)
USD |
NASDAQ |
Apr 24, 16:00
1.875
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Total Liabilities (Quarterly): 37.12M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.12M |
| September 30, 2023 | 38.58M |
| June 30, 2023 | 38.57M |
| March 31, 2023 | 38.76M |
| December 31, 2022 | 38.35M |
| September 30, 2022 | 36.64M |
| June 30, 2022 | 36.64M |
| March 31, 2022 | 29.37M |
| Date | Value |
|---|---|
| December 31, 2021 | 35.81M |
| September 30, 2021 | 39.97M |
| June 30, 2021 | 40.44M |
| March 31, 2021 | 45.81M |
| December 31, 2020 | 44.01M |
| September 30, 2020 | 33.47M |
| December 31, 2019 | 141.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
29.37M
Minimum
Mar 2022
141.95M
Maximum
Dec 2019
45.03M
Average
38.57M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Sagimet Biosciences Inc | 5.654M |
| Catalyst Pharmaceuticals Inc | 82.23M |
| Codexis Inc | 49.95M |
| Annexon Inc | 47.12M |
| Inhibrx Inc | 264.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 207.30M |
| Shareholders Equity (Quarterly) | 170.18M |